Chemours CC
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Chemours (CC) Core Market Data and Business Metrics
Latest Closing Price
$13.06Price-Earnings Ratio
22.91Total Outstanding Shares
149.44 Million SharesDividend
$0.25 Per Share QuarterlySIC Description
Chemicals & Allied ProductsPrimary Exchange
New York Stock ExchangeHeadquarters
1007 Market Street, Wilmington, DE, 19801
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 3,201,676 Shares | 3.29 | 3/14/2025 | 10,529,109 Shares |
| 2,392,033 Shares | 3.68 | 2/28/2025 | 8,805,518 Shares |
| 1,841,516 Shares | 4.2 | 2/14/2025 | 7,741,996 Shares |
| 1,563,389 Shares | 4.65 | 1/31/2025 | 7,269,182 Shares |
| 1,715,754 Shares | 4.26 | 1/15/2025 | 7,313,562 Shares |
| 1,638,960 Shares | 4.51 | 12/31/2024 | 7,389,996 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $-1.04 Billion |
| Net Cash Flow From Investing Activities | $-353 Million |
| Net Cash Flow From Investing Activities, Continuing | $-353 Million |
| Net Cash Flow From Operating Activities | $-633 Million |
| Net Cash Flow, Continuing | $-1.02 Billion |
| Exchange Gains/Losses | $-22 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Diluted Earnings Per Share | $0.57 |
| Net Income/Loss Available To Common Stockholders, Basic | $86 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $0 |
| Research and Development | $109 Million |
| Preferred Stock Dividends And Other Adjustments | $0 |
| Income Tax Expense/Benefit, Deferred | $-27 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $-7 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $-7 Million |
| Other Comprehensive Income/Loss | $-93 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity | $605 Million |
| Other Current Liabilities | $562 Million |
| Liabilities | $6.91 Billion |
| Noncurrent Assets | $4.49 Billion |
| Prepaid Expenses | $71 Million |
| Other Current Assets | $713 Million |
Historical Dividends
Current dividend: $0.25 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 14, 2025 | Mar 14, 2025 | Feb 28, 2025 | $0.25 | Quarterly |
| Oct 23, 2024 | Dec 16, 2024 | Nov 15, 2024 | $0.25 | Quarterly |
| Jul 24, 2024 | Sep 13, 2024 | Aug 15, 2024 | $0.25 | Quarterly |
| Apr 29, 2024 | Jun 14, 2024 | May 15, 2024 | $0.25 | Quarterly |
| Feb 12, 2024 | Mar 15, 2024 | Feb 26, 2024 | $0.25 | Quarterly |
| Oct 26, 2023 | Dec 15, 2023 | Nov 15, 2023 | $0.25 | Quarterly |